Docetaxel, cisplatin, and fluorouracil with pegfilgrastim on day 3 as neoadjuvant chemotherapy for esophageal cancer
ConclusionAdministration of pegfilgrastim on day 3 was not sufficient to prevent FN due to DCF treatment, and prophylactic administration of both pegfilgrastim and antibiotics could be a solution.
Source: Cancer Medicine - Category: Cancer & Oncology Authors: Osamu Maeda,
Satoshi Furune,
Mitsuro Kanda,
Kazushi Miyata,
Dai Shimizu,
Shizuki Sugita,
Kazuki Nishida,
Masahiko Ando,
Yasuhiro Kodera,
Yuichi Ando Tags: RESEARCH ARTICLE Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Docetaxel | Esophagus Cancer | Levaquin | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Study | Taxotere